Clinical-Epidemiological Characteristics and Mortality in Patients with Sickle Cell Anemia: A Retrospective Cohort Study of 1980 at 2018

被引:2
作者
Pompeo, Carolina Mariano [1 ]
Ferreira Junior, Marcos Antonio [1 ]
de Queiroz Cardoso, Andreia Insabralde [1 ]
Souza, Mercy da Costa [2 ]
Frota, Oleci Pereira [1 ]
Mota, Felipe Machado [1 ]
Ivo, Maria Lucia [2 ]
机构
[1] Univ Fed Mato Grosso do Sul, Integrated Inst Hlth, Campo Grande, MS, Brazil
[2] Univ Fed Mato Grosso do Sul, Grad Program Hlth & Dev Midwest Reg, Campo Grande, MS, Brazil
来源
INTERNATIONAL JOURNAL OF GENERAL MEDICINE | 2022年 / 15卷
关键词
hematologic diseases; early diagnosis; neonatal screening; survival; epidemiology; DISEASE; HYDROXYUREA; CHILDREN; MORBIDITY; AMERICA; ADULTS; LIVER; RISK;
D O I
10.2147/IJGM.S342971
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose: To analyze the clinical-epidemiological characteristics and mortality in patients with sickle-cell anemia (SCA). Patients and Methods: A cohort study with retrospective data, conducted in two reference hospitals for SCA treatment from January 1980 to December 2018, recorded in two reference services. With a 5% significance level, the Chi-Square and Student's t-tests were employed in the inferential statistical analysis. Results: A total of 128 patients with SCA were studied. Diagnosis up to the fifth day of life was made in 10 patients. There were 19 deaths, of which 12 (63.2%) were female, and the average age at death was 27.05 (+/- 14.78) years. The leading causes of death were septic shock and cardiogenic shock. The use of invasive medical devices was considered a risk factor for death (RR=2.63; 95% CI=1.16-5.96; p=0.018), and monitoring time up to 20 years presented a 31% reduction in the risk of dying (RR=0.31; 95% CI=0.12- 0.82; p=0.011) when compared to the monitoring of more than 20 years. Conclusion: These findings are to be considered in the treatment of patients with SCA, mainly regarding early diagnosis and access to the treatment immediately afterward, since they are fundamental in improving survival and reducing severe complications.
引用
收藏
页码:1057 / 1074
页数:18
相关论文
共 68 条
[11]   Longitudinal Analysis of Patient Specific Predictors for Mortality in Sickle Cell Disease [J].
Curtis, Susanna A. ;
Danda, Neeraja ;
Etzion, Zipora ;
Cohen, Hillel W. ;
Billett, Henny H. .
PLOS ONE, 2016, 11 (10)
[12]  
de Araujo OMR, 2016, INT ARCH MED, P9
[13]   Mortality in children, adolescents and adults with sickle cell anemia in Rio de Janeiro, Brazil [J].
de Castro Lobo, Clarisse Lopes ;
Nascimento, Emilia Matos ;
Carvalho de Jesus, Leonardo Jose ;
de Freitas, Thiago Gotelip ;
Lugon, Jocemir Ronaldo ;
Ballas, Samir K. .
HEMATOLOGY TRANSFUSION AND CELL THERAPY, 2018, 40 (01) :37-42
[14]  
de Montalembert M, 2019, HEMATOL-AM SOC HEMAT, P490, DOI 10.1182/hematology.2019000053
[15]   Mortality in children with sickle cell disease in main-land France from 2000 to 2015 [J].
Desselas, Emilie ;
Thuret, Isabelle ;
Kaguelidou, Florentia ;
Benkerrou, Malika ;
de Montalembert, Mariane ;
Odievre, Marie-Helene ;
Lesprit, Emmanuelle ;
Rumpler, Eva ;
Fontanet, Arnaud ;
Pondarre, Corinne ;
Brousse, Valentine .
HAEMATOLOGICA, 2020, 105 (09) :E440-E443
[16]   Prevalence of sickle cell disease in adults with delayed diagnosis [J].
Ferreira Sarat, Caroline Neris ;
Ferraz, Mayara Bontempo ;
Ferreira Junior, Marcos Antonio ;
Gaetano Correa Filho, Ruy Alberto ;
de Souza, Albert Schiaveto ;
de Queiroz Cardoso, Andreia Insabralde ;
Ivo, Maria Lucia .
ACTA PAULISTA DE ENFERMAGEM, 2019, 32 (02) :202-209
[17]   Cardiovascular complications and risk of death in sickle-cell disease [J].
Gladwin, Mark T. .
LANCET, 2016, 387 (10037) :2565-2574
[18]   Cardiovascular manifestations of sickle cell disease [J].
Hammoudi, Nadjib ;
Lionnet, Francois ;
Redheuil, Alban ;
Montalescot, Gilles .
EUROPEAN HEART JOURNAL, 2020, 41 (13) :1365-+
[19]   Sickle cell in sickle cell disease in Latin America and the United States [J].
Huttle, Alexandra ;
Maestre, Gladys E. ;
Lantigua, Rafael ;
Green, Nancy S. .
PEDIATRIC BLOOD & CANCER, 2015, 62 (07) :1131-1136
[20]  
Institute of Research, TEACH DIAGN ASS PAR